Generali Investments Cee, Investicni Spolecnost, A.S. Bio N Tech Se Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Bio N Tech Se stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 1,200 shares of BNTX stock, worth $143,928. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$143,928% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
362Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$986 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$542 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$529 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...